Lenalidomide in Combination with Rituximab, Dexamethasone, High-dose ARA-C and Cisplatinum As Salvage Therapy in Refractory or Relapsed Aggressive B-cell Non-Hodgkin-Lymphoma - an Open-Label, Multicentre Phase I/II Study (DSHNHL-R6)
Annals of Hematology（2025）
关键词
Relapsed/refractory B-cell lymphoma,Salvage therapy,R-DHAP,lenalidomide
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要